- Supply chain disruptions due to climate events and geopolitical factors.
- Maintaining high quality and safety standards across operations.
KISSEI PHARMACEUTICAL CO., LTD.
Greenhouse gas emissions & sustainability report data
In its 2022 reporting, KISSEI PHARMACEUTICAL CO., LTD. disclosed greenhouse gas emissions of 16.9K tCO2e/year (Scope 1+2 in 2022). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
16.9K tCO2e/year (Scope 1+2 in 2022)
2022
Renewable Energy
74% (2022)
of total energy
Energy Use
5.2K MWh/year (2021)
2022
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2022 | 16.9K tCO2e/year (Scope 1+2 in 2022) |
| 2021 | 16.9K tons/year (CO2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced CO2 emissions by 19% (Scope 1+2) from 2013 levels by 2022; aiming for 46% reduction by 2030.
- Achieved 74% renewable energy share by 2022 (aiming for 74% by 2030).
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce water consumption by 10% by 2025 (example, not explicitly stated in report).
📅 Medium-term
- Achieve 46% reduction in CO2 emissions (Scope 1+2) by 2030.
- Achieve 74% renewable energy by 2030.
🔭 Long-term
- Net-zero emissions by 2050 (implied, not explicitly stated in report).
🌱 ESG Focus Areas
EnvironmentalSocialGovernance